ID   UBR1_CAEEL              Reviewed;        2058 AA.
AC   P91133;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   07-APR-2021, entry version 137.
DE   RecName: Full=E3 ubiquitin-protein ligase ubr-1;
DE            EC=2.3.2.27;
DE   AltName: Full=N-recognin-1;
DE   AltName: Full=RING-type E3 ubiquitin transferase ubr-1;
DE   AltName: Full=Ubiquitin-protein ligase E3-alpha;
GN   Name=ubr-1 {ECO:0000312|WormBase:C32E8.11};
GN   ORFNames=C32E8.11 {ECO:0000312|WormBase:C32E8.11};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   INTERACTION WITH UBC-1.
RX   PubMed=14732404; DOI=10.1016/j.ydbio.2003.09.037;
RA   Crowe E., Candido E.P.M.;
RT   "Characterization of C. elegans RING finger protein 1, a binding partner of
RT   ubiquitin-conjugating enzyme 1.";
RL   Dev. Biol. 265:446-459(2004).
RN   [3]
RP   FUNCTION, IDENTIFICATION IN COMPLEX WITH CED-3 AND ATE-1, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF 136-MET--GLU-163.
RX   PubMed=28602583; DOI=10.1016/j.devcel.2017.05.013;
RA   Weaver B.P., Weaver Y.M., Mitani S., Han M.;
RT   "Coupled Caspase and N-End Rule Ligase Activities Allow Recognition and
RT   Degradation of Pluripotency Factor LIN-28 during Non-Apoptotic
RT   Development.";
RL   Dev. Cell 41:665-673(2017).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF 18-ARG--TRP-25;
RP   821-GLU--PHE-2058 AND 1864-GLN--PHE-2058.
RX   PubMed=29649217; DOI=10.1371/journal.pgen.1007303;
RA   Chitturi J., Hung W., Rahman A.M.A., Wu M., Lim M.A., Calarco J., Baran R.,
RA   Huang X., Dennis J.W., Zhen M.;
RT   "The UBR-1 ubiquitin ligase regulates glutamate metabolism to generate
RT   coordinated motor pattern in Caenorhabditis elegans.";
RL   PLoS Genet. 14:E1007303-E1007303(2018).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end
CC       rule pathway (By similarity). Recognizes and binds to proteins bearing
CC       specific N-terminal residues that are destabilizing according to the N-
CC       end rule, leading to their ubiquitination and subsequent degradation
CC       (By similarity). In complex with ced-3, required for the ced-3-mediated
CC       cleavage and subsequent degradation of the heterochronic protein lin-28
CC       to regulate seam cell fate patterning during larval development
CC       (PubMed:28602583). Negatively regulates glutamate metabolism through
CC       the aspartate aminotransferase got-1.2 (PubMed:29649217). Modulation of
CC       glutamate levels most likely controls locomotory behavior, in
CC       particular backwards locomotion or 'reversals' (PubMed:29649217).
CC       {ECO:0000250|UniProtKB:Q8IWV7, ECO:0000269|PubMed:28602583,
CC       ECO:0000269|PubMed:29649217}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with ubc-1 (Probable). Component of a complex
CC       containing at least ced-3, ubr-1 and possibly ate-1 (PubMed:28602583).
CC       Within complex interacts with ced-3 (via the p17 subunit); this
CC       interaction is required for the ced-3-mediated cleavage and subsequent
CC       degradation of the heterochronic protein lin-28 (PubMed:28602583).
CC       {ECO:0000269|PubMed:28602583, ECO:0000305|PubMed:14732404}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in pharyngeal muscles, body wall muscles
CC       and a subset of neurons throughout postembryonic development
CC       (PubMed:29649217). Prominently expressed in premotor interneurons, but
CC       not expressed in ventral cord motor neurons (PubMed:29649217). Weakly
CC       expressed in hypodermal seam cells (PubMed:29649217).
CC       {ECO:0000269|PubMed:29649217}.
CC   -!- DOMAIN: The RING-H2 zinc finger is an atypical RING finger with a His
CC       ligand in place of the fourth Cys of the classical motif.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown enhances the excessive
CC       seam cell proliferation phenotype of the ain-1 ku322 mutant.
CC       {ECO:0000269|PubMed:28602583}.
CC   -!- SIMILARITY: Belongs to the UBR1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284601; CCD66417.1; -; Genomic_DNA.
DR   PIR; T25604; T25604.
DR   RefSeq; NP_491231.2; NM_058830.4.
DR   SMR; P91133; -.
DR   BioGRID; 37427; 8.
DR   IntAct; P91133; 1.
DR   STRING; 6239.C32E8.11; -.
DR   EPD; P91133; -.
DR   PaxDb; P91133; -.
DR   PeptideAtlas; P91133; -.
DR   PRIDE; P91133; -.
DR   EnsemblMetazoa; C32E8.11.1; C32E8.11.1; WBGene00016326.
DR   GeneID; 171953; -.
DR   KEGG; cel:CELE_C32E8.11; -.
DR   UCSC; C32E8.11; c. elegans.
DR   CTD; 171953; -.
DR   WormBase; C32E8.11; CE40441; WBGene00016326; ubr-1.
DR   eggNOG; KOG1140; Eukaryota.
DR   GeneTree; ENSGT00950000183075; -.
DR   HOGENOM; CLU_001801_2_0_1; -.
DR   InParanoid; P91133; -.
DR   OMA; WESEWET; -.
DR   OrthoDB; 81415at2759; -.
DR   PhylomeDB; P91133; -.
DR   Reactome; R-CEL-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:P91133; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00016326; Expressed in multi-cellular organism and 5 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:WormBase.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:2000212; P:negative regulation of glutamate metabolic process; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0043058; P:regulation of backward locomotion; IMP:UniProtKB.
DR   GO; GO:0071596; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; IBA:GO_Central.
DR   Gene3D; 3.30.1390.10; -; 1.
DR   InterPro; IPR003769; ClpS_core.
DR   InterPro; IPR044046; E3_ligase_UBR-like_C.
DR   InterPro; IPR014719; Ribosomal_L7/12_C/ClpS-like.
DR   InterPro; IPR039164; UBR1-like.
DR   InterPro; IPR003126; Znf_UBR.
DR   PANTHER; PTHR21497; PTHR21497; 1.
DR   Pfam; PF02617; ClpS; 1.
DR   Pfam; PF18995; PRT6_C; 1.
DR   Pfam; PF02207; zf-UBR; 1.
DR   SMART; SM00396; ZnF_UBR1; 1.
DR   SUPFAM; SSF54736; SSF54736; 1.
DR   PROSITE; PS51157; ZF_UBR; 1.
PE   1: Evidence at protein level;
KW   Membrane; Metal-binding; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..2058
FT                   /note="E3 ubiquitin-protein ligase ubr-1"
FT                   /id="PRO_0000056138"
FT   TRANSMEM        1695..1715
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         93..164
FT                   /note="UBR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00508"
FT   ZN_FING         1217..1335
FT                   /note="RING-type; atypical"
FT   MUTAGEN         18..25
FT                   /note="Missing: In hp820; animals are viable, but display
FT                   defective locomotion that progressively develops from the
FT                   late larval stage into adulthood. Animals are capable of
FT                   backwards locomotion or 'reversals' movements, but exhibit
FT                   limited body flexing, with decreased body curvature during
FT                   reversals, increased duration of reversals and a reduced
FT                   frequency of reversal initiation compared to wild-type.
FT                   Reduced bending is due to a defective activation pattern of
FT                   A class motor neurons, whereby the posterior clusters of A
FT                   class motor neurons DA7, VA10 and VA11, that innervate body
FT                   wall muscles to execute reversals, are activated at the
FT                   same time, which is in contrast to wild-type. Animals also
FT                   display morphological and synaptic activity defects in AVA
FT                   and AVE interneurons. Increases glutamate levels which is
FT                   likely through increased got-1.2 activity. Defective
FT                   reversals movement phenotype and increased glutamate levels
FT                   are rescued in the got-1.2 hp731 mutant."
FT                   /evidence="ECO:0000269|PubMed:29649217"
FT   MUTAGEN         34..2058
FT                   /note="Missing: In hp821; animals are viable, but display
FT                   defective locomotion that progressively develops from the
FT                   late larval stage into adulthood. Animals are capable of
FT                   backwards locomotion or 'reversals' movements, but exhibit
FT                   limited body flexing, with decreased body curvature during
FT                   reversals, increased duration of reversals and a reduced
FT                   frequency of reversal initiation compared to wild-type.
FT                   Reduced bending is due to a defective activation pattern of
FT                   A class motor neurons, whereby the posterior clusters of A
FT                   class motor neurons DA7, VA10 and VA11, that innervate body
FT                   wall muscles to execute reversals, are activated at the
FT                   same time, which is in contrast to wild-type. Animals also
FT                   display morphological and synaptic activity defects in AVA
FT                   and AVE interneurons. Increases glutamate levels which is
FT                   likely through increased got-1.2 activity. Defective
FT                   reversals movement phenotype and increased glutamate levels
FT                   are rescued in the got-1.2 hp731 mutant."
FT                   /evidence="ECO:0000269|PubMed:29649217"
FT   MUTAGEN         136..163
FT                   /note="Missing: In tm5996; increases lin-28 protein levels
FT                   30 hours post feeding. Enhances the excessive seam cell
FT                   proliferation phenotype and enhances the delay in temporal
FT                   cell fate patterning of seam cells during the progression
FT                   of larval development of the ain-1 ku322 mutant."
FT                   /evidence="ECO:0000269|PubMed:28602583"
FT   MUTAGEN         1864..2058
FT                   /note="Missing: In hp684; animals are viable, but display
FT                   defective locomotion that progressively develops from the
FT                   late larval stage into adulthood. Animals are capable of
FT                   backwards locomotion or 'reversals' movements, but exhibit
FT                   limited body flexing, with decreased body curvature during
FT                   reversals, increased duration of reversals and a reduced
FT                   frequency of reversal initiation compared to wild-type.
FT                   Reduced bending is due to a defective activation pattern of
FT                   A class motor neurons, whereby the posterior clusters of A
FT                   class motor neurons DA7, VA10 and VA11, that innervate body
FT                   wall muscles to execute reversals, are activated at the
FT                   same time, which is in contrast to wild-type. Animals also
FT                   display morphological and synaptic activity defects in AVA
FT                   and AVE interneurons. Increases glutamate levels which is
FT                   likely through increased got-1.2 activity. Defective
FT                   reversals movement phenotype and increased glutamate levels
FT                   are rescued in the got-1.2 hp731 mutant."
FT                   /evidence="ECO:0000269|PubMed:29649217"
SQ   SEQUENCE   2058 AA;  232816 MW;  DBAE0014CE89F7AC CRC64;
     MIVDLIQSAR QGEWAQVRQL LLKHWLVQVP EVFEVNSDLP WDNTAANERI LGSQGEILLA
     PLVSAFVLDV RNTKSTLEAM NGIAGVDPAR RGQICGHVFK NGELTYTCLD CATDGTCVMC
     LQCFEVSIHK SHKYKMHSSS GSGYCDCGDA DAWTEGYACA NHEKKDDEEA AVLAPELKKR
     CEQLVEIILQ FSLSMITHKD DLKLPEIFEK MKPEVTNEAQ QYLTVLYNDE THTYESVIKV
     LELYIHCTKD QAMLVATIVD REGRSAVKLG SKADCTKAKD DVQRKTARDP TSIRRSSNHN
     LPLSVKVMDT TLFALQNFSI SLLTWLNTQM DVFPPLREIV GEILLSSKFA LKKNYTRKMK
     SEDQRLVAGI IRNVMVLPDD EEEELFALDG RMDVDEMDDD DIGGEALQME IDADDEEEIT
     AALAGVSEHQ ESPGPSRDSS TFTMLENILL QDTQMWKAGR SILHQMLMRT VFMIYDQKVR
     FAKAFMLHYN EIYEDFIKDD HEMDVSVVGL SVQFMTVPSL ARKLVAEDQA FSVISKAIRD
     QTDKFVKYYN DGKIARFDFT SRSFPPELRR SLHITRDMAY ILNAVPSESD WNRELIDGFV
     QGFADFLLFL QHLQGMDEVK RQAVEHQVWE SEWETAFNIL LRLKDAISMI IGWAETNEEV
     HNRLMIMCLE LMNRMPPVYT KSEEDTYELT VTINGESCRI SHFDVLKSST SVHQPVVRII
     AGLFSASNYT GFLLNRSNNS HTSLNQERIK ELINCKDETN LYELSLRVLV LCAQSNATLW
     RRNGFSLINQ IHNYFSPLCR NEMFDRDVLM MQVGAALTPS TKFIFHLLHR FRLFKWATSE
     FEQDKANEKP AKPESEDLSK TLVMIAEEFI QCLILILCER YTYGVGKTRP MDQMKREVIH
     ILCTGSHTFS HIQQKMSHDI NSKRLSLHEA VNLVADFRKP LATTAGQFHC KESSLPTYSP
     FFMHYSKSDQ SAAEQSQARV RAKMEKSVRA CAPPILPDFQ TFFERIPEIL TTNVLIHVVR
     LIIDRTARRS RFSSDRLFHK TLYLIGIALN EEEKNPSFGF TQRAEESIGL LSLLEGLVGK
     PESSICPILL EVTVEKYRKL IKARAGVPEA APAPENKPAQ SEEEIKAKRA ARAAEMRQKA
     MAKMSNMQSK FMKKIEDEEK KDESQTPSEK SETVVKKDDY DNKHFFDEDV VKQVGHDFPV
     CIGANKWHAE LVKPRTLTCI LCQEDEIIAP QQGKPMVCAA FIQQSQLFTH KNKNGELMTA
     SSGTISTRDL LTAPATLQYG VDVSTCSHSM HYECYRSLAE ANRSRESLRA RQVGQHSHKM
     VDTENGEYQC PLCKRLSNAA IPVLPAYQLT NQNGFSTVSG AGKENFDTWV ARVKRNLEMP
     LSSESVSKKG HSRKRSHSER SLLDLEKLSK DPDTANTSAG VLQFGAMEMS SATHMPASAE
     SQMLMTTSPS QDDVEFYNEL AAMFVDQDVN NTTSPAATPE TIPAIGSSSR IPESQESGKK
     PLSSQIQHVL YSLIRPFPAL INSNRICSSS FEGFEEPIKD LGKNMMKFRK RGNELKTNFI
     EKHLKGYVIS TVTWQSTAHV ARAISSYLHY DKKPLFGALN TRQRDCLSAM ARLCASLSHN
     MQFLLHAVSD MLRVFLCEPP RPKLAQTPGS PLLSAPSTSS FTPAPAQIPH SGTNFAFLVQ
     LFNPAGPRKN VNLNILQIDI LSLAISLMMT IGWTWNNGTQ SMNSSSTHQK ARLLTPDGSV
     DEAYVLRLSL LAHYFQIIAT HSEADGNDVN MEEEQESQME VDPVAAQTIR KLYALCHPFD
     GPLRRVDILW RKMEEGAQSL LRPIALLYHF ITLVDPPEAL KDPSINSSEP LFRYLGLPHK
     IEEQISGSML EKLFTMWSSS IPSDQALRQD LVVQPVRPNL LVELPEKYSQ LINQVATFKC
     PTIPIEESTS NVPTLCLVCG TILCSQAYCC QKIINKQSYG ACRYHMSQCS GSVGMFLRVR
     DCSLVLMTTR KRGCFRPAPY VDEFGEVDQG FRRGNPLHLN PELYQKLKSL WLQQGITEEV
     VNYNEIDFRN VQYDWGHF
//
